The Diabetech podcast brought together clinicians, executives, and people living with diabetes to dig into what’s working, what’s failing, and what’s coming next for diabetes tech. In case you missed it, here are the top 10 podcast episodes of the year.

After posting a video that sparked nearly 1,000 user comments, it became clear that Dexcom G7 reliability issues weren’t unique incidents. This conversation brings together Kamil from Nerdabetic and endocrinologist Dr. David Ahn to unpack what users are actually experiencing—from connectivity failures to applicator issues like “goosenecking.” We also discuss the FDA warning letter Dexcom received, whether increased scrutiny comes with market dominance, and why transparency matters more than ever when users rely on these systems daily.

After using Omnipod 5 for three months, this episode breaks down what day-to-day life with the system was like. Justin walks using the iPhone app, preferred wear locations, managing workouts, and key settings tweaks, while also comparing Omnipod 5’s customization and flexibility to open-source systems like Loop and Trio.

This episode takes the conversation straight to the source. We sit down with Dexcom’s now CEO, Jake Leach, to address recent FDA warnings, a Class 1 recall tied to faulty alerts, and mounting user frustration around G7 accuracy and sensor connection. Beyond the challenges, we explore what’s ahead—including the 15-day G7 sensor, AI-powered food tracking via image recognition, and the new Stelo–Oura Ring integration that merges glucose, sleep, and recovery data. It’s a look inside how Dexcom is responding—and what the future of CGM could look like.

Sequel Med Tech’s twiist pump launched in July 2025, and in this episode we spoke with CEO Alan Lotvin about what users can expect. We explore twiist’s Libre 3 Plus integration, its advanced iiSure occlusion detection technology designed to improve insulin delivery reliability, and a pharmacy-based access model that could dramatically change how pumps are obtained. For anyone following the next wave of tubed pump innovation, this is essential listening. Keep an eye out for our twiist review coming soon!

This interview is a deep dive of Tandem’s upcoming tech with its Sr. Director of Product Marketing, Ben Mar. We get a hands-on demo of the SteadiSet 7-day infusion set, discuss the upcoming tubeless Mobi option, and cover Libre 3 Plus integration and Android app development. We also address recent safety warnings and answer questions about global availability and what’s next.

ATTD 2025 delivered one of the biggest weeks in diabetes tech we’ve seen in years. Joined by endocrinologist Dr. David Ahn, we break down the most important announcements—including the twiist pump, the newly unveiled Kaleido 2, Tandem’s Control-IQ+ update, and Dexcom’s 15-day sensor.

In this conversation with Chief Product Officer Mike Mensinger, we unpack recent updates like expanded CGM integrations, a redesigned pump, and the new Blue Circle Follower App. We also look ahead to what’s coming—including a tubeless pump design called “mint,” a fully closed-loop algorithm, and a bi-hormonal pump using glucagon.

This episode offers a rare long-term perspective, following a user who has lived with diabetes since the 1950s. Michael Dardenelle shares his experience transitioning from the Tandem t:slim X2 with Dexcom G7 to Medtronic’s 780G system with Guardian 4. We discuss algorithm performance, time-in-range results, daily usability, and what features he misses from Tandem.

After decades of hearing that a cure is always “5–10 years away," journalist and T1D Ginger Vieira walks through the most promising developments in diabetes cure research. This episode explores companies that have already cured patients to breakthroughs that eliminate the need for immunosuppressants.

This episode explores Glucotrack’s implantable continuous blood glucose monitor (CBGM), which aims to measure glucose directly from the bloodstream. Joined by Glucotrack’s CEO and Chief Scientific Officer, we break down how the device works, how it’s implanted, and why blood-based sensing could dramatically improve accuracy and automated insulin delivery systems in the future.

Disclaimer: Diabetech content is not medical advice—it’s for educational purposes only. Always consult with a physician before making changes to your healthcare.